Stacy Amin, head of Morrison Foerster’s FDA + Healthcare Regulatory and Compliance Group, is speaking on the “Life Sciences and Pharma Considerations” panel on April 15, 2024, at the Federal Circuit Bar Association’s Global Series.
For more information, visit the FCBA website.